Cargando…

Regulatory B and T lymphocytes in multiple sclerosis: friends or foes?

Current clinical experience with immunomodulatory agents and monoclonal antibodies in principle has established the benefit of depleting lymphocytic populations in relapsing–remitting multiple sclerosis (RRMS). B and T cells may exert multiple pro-inflammatory actions, but also possess regulatory fu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vasileiadis, Georgios K., Dardiotis, Efthymios, Mavropoulos, Athanasios, Tsouris, Zisis, Tsimourtou, Vana, Bogdanos, Dimitrios P., Sakkas, Lazaros I., Hadjigeorgiou, Georgios M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2018
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6230324/ https://www.ncbi.nlm.nih.gov/pubmed/30415321 http://dx.doi.org/10.1007/s13317-018-0109-x

Ejemplares similares

A comprehensive analysis of antigen-specific autoimmune liver disease related autoantibodies in patients with multiple sclerosis
por: Tsouris, Zisis, et al.
Publicado: (2020)

Tetracyclines Diminish In Vitro IFN-γ and IL-17-Producing Adaptive and Innate Immune Cells in Multiple Sclerosis
por: Florou, Despoina T., et al.
Publicado: (2021)

Immune responses against Helicobacter pylori-specific antigens differentiate relapsing remitting from secondary progressive multiple sclerosis
por: Efthymiou, Georgios, et al.
Publicado: (2017)

Anti-MOG Positive Bilateral Optic Neuritis and Brainstem Encephalitis Secondary to COVID-19 Infection: A Case Report
por: Tsouris, Zisis, et al.
Publicado: (2022)

Deciphering the role of DNA methylation in multiple sclerosis: emerging issues
por: Sokratous, Maria, et al.
Publicado: (2016)

Multiple Sclerosis: Shall We Target CD33?
por: Siokas, Vasileios, et al.
Publicado: (2020)

The effect of Apremilast on signal transduction and IL-10 production in CD39high regulatory B cells in patients with psoriatic arthritis
por: Sakkas, Lazaros I., et al.
Publicado: (2018)

Brain atrophy in multiple sclerosis: mechanisms, clinical relevance and treatment options
por: Andravizou, Athina, et al.
Publicado: (2019)

The Role of Flavonoids in Inhibiting Th17 Responses in Inflammatory Arthritis
por: Kelepouri, Dimitra, et al.
Publicado: (2018)

MOBP rs616147 Polymorphism and Risk of Amyotrophic Lateral Sclerosis in a Greek Population: A Case-Control Study
por: Liampas, Ioannis, et al.
Publicado: (2021)

Genetic Risk Factors for Essential Tremor: A Review
por: Siokas, Vasileios, et al.
Publicado: (2020)

Searching for Possible Links between Alzheimer’s Disease and Systemic Sclerosis
por: Dardiotis, Efthymios, et al.
Publicado: (2020)

Curcumin for the Management of Periodontitis and Early ACPA-Positive Rheumatoid Arthritis: Killing Two Birds with One Stone
por: Asteriou, Eleni, et al.
Publicado: (2018)

The Role of p38 MAPK in the Aetiopathogenesis of Psoriasis and Psoriatic Arthritis
por: Mavropoulos, Athanasios, et al.
Publicado: (2013)

ADORA2A rs5760423 and CYP1A2 rs762551 Polymorphisms as Risk Factors for Parkinson’s Disease
por: Siokas, Vasileios, et al.
Publicado: (2021)

A sharp decrease of Th17, CXCR3(+)-Th17, and Th17.1 in peripheral blood is associated with an early anti-IL-17-mediated clinical remission in psoriasis
por: Tsiogkas, Sotirios G, et al.
Publicado: (2022)

Flow Cytometric Detection of p38 MAPK Phosphorylation and Intracellular Cytokine Expression in Peripheral Blood Subpopulations from Patients with Autoimmune Rheumatic Diseases
por: Mavropoulos, Athanasios, et al.
Publicado: (2014)

p38 MAPK Signaling in Pemphigus: Implications for Skin Autoimmunity
por: Mavropoulos, Athanasios, et al.
Publicado: (2013)

Kawasaki Disease and COVID-19
por: Gkoutzourelas, Athanasios, et al.
Publicado: (2020)

Neurodegeneration and Inflammation—An Interesting Interplay in Parkinson’s Disease
por: Marogianni, Chrysoula, et al.
Publicado: (2020)

Vaccination in Multiple Sclerosis: Friend or Foe?
por: Zrzavy, Tobias, et al.
Publicado: (2019)

Microglia in Multiple Sclerosis: Friend or Foe?
por: Guerrero, Brooke L., et al.
Publicado: (2020)

Thinking Outside the Ischemia Box: Advancements in the Use of Multiple Sclerosis Drugs in Ischemic Stroke
por: Aloizou, Athina-Maria, et al.
Publicado: (2021)

Infections as a cause of autoimmune rheumatic diseases
por: Sakkas, Lazaros I., et al.
Publicado: (2016)

Enterococcus gallinarum as a component of the Autoinfectome: the gut-liver-autoimmune rheumatic disease axis is alive and kicking
por: Bogdanos, Dimitrios P., et al.
Publicado: (2018)

ZEB Proteins in Leukemia: Friends, Foes, or Friendly Foes?
por: Soen, Bieke, et al.
Publicado: (2018)

SARS-CoV-2 and type I interferon signaling in brain endothelial cells: Blurring the lines between friend or foe
por: Vavougios, George D., et al.
Publicado: (2022)

Real-World Assessment of Quality of Life in Patients with Relapsing Remitting Multiple Sclerosis Treated with Teriflunomide for Two Years: Patient-Reported Outcomes from the AURELIO Study in Greece
por: Dardiotis, Efthymios, et al.
Publicado: (2022)

Friend and Foe
Publicado: (1890)

Gallic acid diminishes pro-inflammatory interferon-γ- and interleukin-17-producing sub-populations in vitro in patients with psoriasis
por: Tsiogkas, Sotirios G., et al.
Publicado: (2023)

Signaling lymphocytic activation molecules Slam and cancers: friends or foes?
por: Fouquet, Gregory, et al.
Publicado: (2018)

Mini Review: New Treatments in Psoriatic Arthritis. Focus on the IL-23/17 Axis
por: Sakkas, Lazaros I., et al.
Publicado: (2019)

Regulatory Immune Cells in Idiopathic Pulmonary Fibrosis: Friends or Foes?
por: van Geffen, Chiel, et al.
Publicado: (2021)

Multiparametric autoantibody profiling of patients with systemic sclerosis in Greece
por: Liaskos, Christos, et al.
Publicado: (2018)

Phytoestrogens. Friends or foes?
por: Barrett, J
Publicado: (1996)

Polypill—Friend or Foe?
por: Rishi, Rakesh Kumar
Publicado: (2011)

Antioxidants - friend or foe?
por: Meffert, Hans
Publicado: (2008)

Inflammation: Friend and Foe
por: Kjekshus, John
Publicado: (2015)

Leukocytes: friend or foe
por: Bellingan, G
Publicado: (2000)

Viruses: Friends or foes
por: Michán, Carmen, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_o8cjnggockcc8krk6rrcomovhr